RxDoctor Payments DataLook up a doctor →

Jeremy McConnell, MD

Sleep Medicine · Bradenton, FLNPI 1700871969

Payments from drug & device makers

$615,272in general payments, 2019–2025

Across 1,142 payments — averaging $538.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$163K
  • Inspire Medical Systems, Inc.$136K
  • Lilly USA, LLC$123K
  • Harmony Biosciences LLC$80K
  • Idorsia Pharmaceuticals US Inc$48K
  • Avadel CNS Pharmaceuticals, LLC$32K
  • plus $33K from 22 others

What the payments were for

  • Consulting fees$167,28027%
  • Speaking & faculty fees$366,30460%
  • Travel & lodging$51,5348%
  • Food & beverage$29,7685%
  • Education$3660%
  • Entertainment$200%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$615,272 in reported general payments places this provider in the 95th percentile of 77 sleep medicine providers in Florida.

See all sleep medicine providers in Florida

Medicare billing

Part B allowed, 2024
$964,899
Medicare patients
1,645
Services billed
13,457

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
WakixPitolisant Hcl13$102,182
OzempicSemaglutide18$26,113
QuviviqDaridorexant Hcl26$15,233
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine20$2,989
Modafinil49$1,827
Gabapentin156$1,365
Armodafinil16$1,036
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine12$694
Temazepam56$686
Methylphenidate Hcl22$598
Doxepin Hcl30$490
Clonazepam82$443
Quetiapine Fumarate25$395
Ropinirole Hcl29$390
Trazodone Hcl73$373

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Harmony Biosciences LLCWakix$79,969$102,18213 claims
Novo NordiskOzempic$163,492$26,11318 claims
Idorsia Pharmaceuticals US IncQuviviq$47,904$15,23326 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 77 sleep medicine providers in Florida.

Other sleep medicine in Bradenton

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →